{
    "2019-04-23": [
        [
            {
                "time": "2019-03-31",
                "original_text": "凯莱英2019年第一季度营收增长31% 净利9206万元",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "2019年第一季度",
                        "营收增长",
                        "净利",
                        "9206万元"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-31",
                "original_text": "【国盛医药张金洋团队】凯莱英2019 Q1点评：一季度业绩超预期，CDMO龙头昂首前进",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "2019 Q1",
                        "业绩超预期",
                        "CDMO龙头"
                    ],
                    "sentiment_score": 0.95,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}